NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype.
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. Leuk Res. 2022 12; 123:106965.